Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | PGR | P06401 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.49 |
| ▸ | HTR2B | P41595 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.49 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.49 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6047529 | 0.88 | IDO1 (0.40) | IDO1LMNAMAPTTDP1ALDH1A1 | |
| SCHEMBL4318927 | 0.79 | LMNA (0.61) | IDO1LMNAMAPTTDP1ALDH1A1 | |
| Coenzyme Q1 SCHEMBL1129498 | 0.78 | LMNA (0.73) | IDO1LMNAMAPTTDP1ALDH1A1 | |
| SCHEMBL3171268 | 0.77 | MAOB (0.33) | ALOX15 | |
| SCHEMBL14894680 | 0.76 | MAPT (0.67) | IDO1LMNAMAPTTDP1ALDH1A1 | |
| SCHEMBL13033957 | 0.75 | MAPT (0.61) | IDO1LMNAMAPTTDP1ALDH1A1 | |
| SCHEMBL14895856 | 0.74 | IDO1 (0.62) | IDO1LMNAMAPTTDP1ALDH1A1 | |
| SCHEMBL2625087 | 0.74 | LMNA (0.68) | IDO1LMNAMAPTTDP1ALDH1A1 | |
| SCHEMBL24783643 | 0.74 | IDO1 (0.56) | IDO1LMNAMAPTTDP1ALDH1A1 | |
| SCHEMBL7393149 | 0.74 | MAPT (0.62) | IDO1LMNAMAPTTDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2911656-B1 | QUINONE BASED NITRIC OXIDE DONATING COMPOUNDS FOR OPHTHALMIC USE | NICOX SA (FR) | 2020-12-02 | — | — | EP | disclosed |
| US-9446015-B2 | Quinone based nitric oxide donating compounds for ophthalmic use | NICOX SCIENCE IRELAND (IE) | 2016-09-20 | — | — | US | disclosed |
| WO-2015155234-A1 | QUINONE BASED NITRIC OXIDE DONATING COMPOUNDS | NICOX SCIENCE IRELAND (IE) | 2015-10-15 | — | — | WO | disclosed |
| US-20150283106-A1 | QUINONE BASED NITRIC OXIDE DONATING COMPOUNDS FOR OPHTHALMIC USE | NICOX SA (FR) | 2015-10-08 | — | — | US | disclosed |
| EP-2911656-A1 | QUINONE BASED NITRIC OXIDE DONATING COMPOUNDS FOR OPHTHALMIC USE | Nicox Science Ireland (IE) | 2015-09-02 | — | — | EP | disclosed |
| US-9079821-B2 | Quinone based nitric oxide donating compounds | NICOX SCIENCE IRELAND (IE) | 2015-07-14 | — | — | US | disclosed |
| US-9061962-B2 | Quinone based nitric oxide donating compounds | NICOX SCIENCE IRELAND (IE) | 2015-06-23 | — | — | US | disclosed |
| EP-2707354-B1 | QUINONE BASED NITRIC OXIDE DONATING COMPOUNDS | NICOX SCIENCE IRELAND (IE) | 2015-04-29 | — | — | EP | disclosed |
| US-20140342998-A1 | QUINONE BASED NITRIC OXIDE DONATING COMPOUNDS | NICOX S.A. (FR) | 2014-11-20 | — | — | US | disclosed |
| US-20140135389-A1 | QUINONE BASED NITRIC OXIDE DONATING COMPOUNDS | NICOX SA (FR) | 2014-05-15 | — | — | US | disclosed |
| EP-2722326-A1 | Quinone based nitric oxide donating compounds | NICOX S.A. (FR) | 2014-04-23 | — | — | EP | disclosed |
| EP-2707354-A1 | QUINONE BASED NITRIC OXIDE DONATING COMPOUNDS | Nicox S.A. (FR) | 2014-03-19 | — | — | EP | disclosed |
| WO-2013060673-A1 | QUINONE BASED NITRIC OXIDE DONATING COMPOUNDS | NICOX S.A. (FR) | 2013-05-02 | — | — | WO | disclosed |
| US-8388950-B2 | Coenzyme Q10-containing water-soluble composition and process for production thereof | KANEKA CORPORATION (JP) | 2013-03-05 | — | — | US | disclosed |
| US-20070293572-A1 | Anti-Fatigue Composition | KANEKA CORPORATION (JP) | 2007-12-20 | — | — | US | disclosed |
| US-20070259908-A1 | Mitochondria Activators | KANEKA CORPORATION (JP) | 2007-11-08 | — | — | US | disclosed |
| US-20070243180-A1 | Composition Containing Reduced Coenzyme Q | KANEKA CORPORATION (JP) | 2007-10-18 | — | — | US | disclosed |
| US-20070196349-A1 | Whitening composition containing reduced coenzyme Q | KANEKA CORPORATION (JP) | 2007-08-23 | — | — | US | disclosed |
| US-20070122400-A1 | Composition having liver function protecting effect | KANEKA CORPORATION (JP) | 2007-05-31 | — | — | US | disclosed |
| US-3974187-A | BENZOQUINONES, 6-ALKYL- | WAN YIEH PING | 1976-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070243180-A1 | Composition Containing Reduced Coenzyme Q | NDUFA6, COQ8A, NDUFA9 | IDO1 3575/4885LMNA 2436/4885MAPT 863/4885 |
| US-20070259908-A1 | Mitochondria Activators | CS, TFAM, COQ8A | IDO1 3048/4885LMNA 3777/4885MAPT 1297/4885 |
| US-20070122400-A1 | Composition having liver function protecting effect | SQOR, GPX1, CPT1A | IDO1 563/4885LMNA 2222/4885MAPT 4219/4885 |
| US-20150283106-A1 | QUINONE BASED NITRIC OXIDE DONATING COMPOUNDS FOR OPHTHALMIC USE | NOS1, NOS3, NOS2 | IDO1 419/4885LMNA 2979/4885MAPT 2671/4885 |
| US-20070196349-A1 | Whitening composition containing reduced coenzyme Q | NDUFA7, NDUFA11, NDUFA12 | IDO1 470/4885LMNA 406/4885MAPT 1567/4885 |
| US-20140135389-A1 | QUINONE BASED NITRIC OXIDE DONATING COMPOUNDS | NOS2, NQO1, NOS1 | IDO1 336/4885LMNA 2252/4885MAPT 2605/4885 |
| US-20070293572-A1 | Anti-Fatigue Composition | CPT1B, CPT1A, SLC25A20 | IDO1 1100/4885LMNA 2426/4885MAPT 3437/4885 |
| US-20140342998-A1 | QUINONE BASED NITRIC OXIDE DONATING COMPOUNDS | NOS2, NQO1, NOS1 | IDO1 336/4885LMNA 2252/4885MAPT 2605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.